Amyris is a synthetic biology company dedicated to providing high-performance alternatives to petroleum-sourced fuels, chemicals, and consumer goods. We have created a world-class synthetic biology platform that applies the principles of engineering to biology, pulling together scientists with skills in automation, computing and biology to create an assembly line for genetically manipulating organisms, testing those organisms for production of the desired compound, and iteratively learning from this design-build-test cycle. This allows us to continuously improve our designs, reducing both the time and cost to go from concept to commercial viability with new molecule production. The result of this approach has been the creation of organisms that can produce precursors to an anti-malarial drug, diesel and jet fuels, a cosmetic emollient, and multiple fragrance compounds, each reaching commercial-level production faster than the last.

Website: www.amyris.com